PROPANC BIOPHARMA, INC. (PPCB) Net income 2016–2025
PROPANC BIOPHARMA, INC. (PPCB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$58.9MFY2025 · since FY2016: -$9.4M → -$58.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$58.9M | -3136.6% |
| FY2024 | -$1.8M | +31.6% |
| FY2023 | -$2.7M | -0.1% |
| FY2022 | -$2.7M | -31.2% |
| FY2021 | -$2.0M | +57.3% |
| FY2020 | -$4.7M | +17.7% |
| FY2019 | -$5.8M | +18.2% |
| FY2018 | -$7.0M | +10.5% |
| FY2017 | -$7.9M | +16.4% |
| FY2016 | -$9.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice